25847190 |
Characterizing and Overriding the Structural Mechanism of the Quizartinib-Resistant FLT3 "Gatekeeper" F691L Mutation with PLX3397
Habets, G,
West, BL,
Shah, NP,
Smith, CC,
Lin, KC,
Spevak, W,
Zhang, J,
Sebra, R,
Ibrahim, PN,
Massi, E,
Shellooe, R,
Bashir, A,
Powell, B,
Zhang, C,
Le, MH,
Kasarskis, A,
Burton, EA,
Perl, A,
Pendleton, M,
Tsang, G,
Hsu, HH,
Carias, H,
Matusow, B,
Lasater, EA,
Damon, LE,
Zhang, Y,
Bollag, G
|
|
2015 |
22504184 |
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia
Perl, AE,
Chin, CS,
Schadt, EE,
Shah, NP,
Smith, CC,
Kuriyan, J,
Hunt, JP,
Wang, Q,
Salerno, S,
Wang, S,
Levis, MJ,
Kasarskis, A,
Zarrinkar, PP,
Travers, KJ,
Damon, LE
|
Nature |
2012 |
23430109 |
Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD
Salerno, S,
Zhu, X,
Stewart, WK,
Lasater, EA,
Damon, LE,
Shah, NP,
Smith, CC,
Lin, KC
|
Blood |
2013 |